Don't miss the zoom on our next training session focusing on "brevet d'invention appliqué aux immunothérapies" and register! And check out our upcoming training sessions that are scheduled in June & September.
Take a look at our next scientific eventsto book your agenda: AIS 2017, Bioproduction workshop and I4ID 2017.
L’objectif de cette formation est de fournir les clés en matière de lexique et de stratégie, afin que les participants puissent développer des réflexes de pensée en matière de brevet et avoir des échanges constructifs avec les spécialistes brevets. Pour cela, deux grands points de contenus seront abordés :
Appréhender les particularités du droit des brevets dans le domaine des biomédicaments (objet du brevet, CCP, seconde application thérapeutiques…), basées sur des exemples pris dans le domaine des immunothérapies,
Maîtriser des notions pratiques, comme les clés de lecture d’un brevet et de ses revendications, la recherche de brevets dans une base de données… mais également les diverses applications du brevet.
Après le succès de la journée "BioProduction des anticorps thérapeutiques en France" en mai 2016, MabDesign et MEDICEN organisent une nouvelle journée sur la BioProduction en France le mardi26 septembre 2017 en région parisienne. Plus d'informations sur le programme à venir bientôt.
SAVE THE DATE!
BIOASTER and MabDesign associate their experiences and expertise to organize the first International Congress fully dedicated Immunotherapies for Infectious Diseases (I4ID).
The scientific program of the 2-day I4ID 2017 Congress includes keynote lectures, pitch talks of new creative projects, and industrial talks from big pharmaceutical companies. Furthermore, it will be possible to set up, through an online platform, business meetings during both days (partnering).
Event website online soon!!
Target Product Profile (TPP) 15 juin 2017 Lyon
Tarifs préférentiels jusq'au 15 mai :
Membre MabDesign : 510 €
Non-membre MabDesign : 630 €
Académique : 400 €
Plus d'informations ici.
Anticorps thérapeutiques, de la recherche à la mise sur le marché 14-15 & 28-29 septembre 2017 Lyon
Tarifs forfait 4 jours:
Membre MabDesign : 2 000 €
Non-membre MabDesign : 2 500 € Possibilité de s'inscrire "à la journée" :
Tarif journée membre MabDesign : 600 €
Tarif journée Non-membre MabDesign : 750 €
Plus d'informations ici.
Avez-vous des questions concernant la Propriété Intellectuelle de vos projets scientifiques ?
MabDesign vient de créer un nouveau service de Business Intelligence pour assister ses adhérents sur les aspects de propriété industrielle.
Pour tout savoir sur les services proposés par MabDesign dans les différents domaines de Business Intelligence téléchargez dès maintenant le document pdf ci-dessous !
PETAL : Promega Europe Training and Application Lab
PETAL is the European Training and Application Laboratory of Promega Corp.
We develop new life science applications important to the research community. Many of our projects come directly from researcher requests, or are inspired by data shared by customers. We also provide trainings to researchers. Our training facility in Charbonnières-les-bains (close to Lyon, France) is the perfect place to learn about new protocol developments. Our scientists also offer a variety of life sciences courses that utilize hands-on laboratory activities and case study-based learning such as:
Cell Line identification, 1day
Cell Culture: Theory and Practice, 3days
Cell Culture To Cell Analysis, 5days
Introduction to Proteomics, 1day www.promega.com/PETAL
April 5, 2017 - OSE Immunotherapeutics Presented New Data at AACR* Annual Meeting 2017 on OSE-172 (Effi-DEM), Company’s Checkpoint Inhibitor Blocking Suppressive Myeloid Cells and Inducing Antitumoral Potent T Memory Response. Read more.
April 5, 2017 - ABL awarded BARDA contract to fill live virus-based medical countermeasures. Read more.
March 30, 2017 - iDD biotech signe un accord de licence mondiale exclusive sur son projet d’anticorps breveté ciblant CK8. Read more.
March 29, 2017 - Sanofi et Regeneron : feu vert de la FDA pour Dupixent aux Etats-Unis. Read more.
March 28, 2017 -Erytech collabore avec le Fox Chase Cancer Center pour avancer sa plateforme dans le domaine des maladies métaboliques rares. Read more.
March 27, 2017 - Les Laboratoires Pierre Fabre rejoignent le pole de compétitivité en santé Medicen Paris Région. Read more.
March 27, 2017 - Erytech : des résultats positifs de phase 2b avec eryaspase dans le cancer métastatique du pancréas. Read more.
PARTNER EVENTS
BioProcess European Summit 25-26 April 2017 - Amsterdam
Don’t miss this opportunity to optimise quality and efficiency in bioprocessing, by connecting with an international audience of bioprocessing decision markers, scientists and regulatory authorities from upstream, downstream, cell line development, process analytics, viral safety and vaccines. MabDesign's members benefit from a 15% discount on the registration fees. Ask for your reduction code!
2nd Annual advances in immuno-onclogy Congress 15-16 May 2017 - London, UK
36 presentations and case studies focusing on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling. 4 interactive streams. MabDesign's members benefit from a 20% discount on the registration fees. Ask for your reduction code!
Congrès A3P BioProduction Lyon - 31 Mai / 1er juin 2017
In the upcoming BIOMANUFACTURING A3P CONGRESS, you will have the opportunity to learn about key trends, methodologies and insights on manufacturing, process development, quality management and compliance of bioproducts.
You will meet Senior VPs, Heads, Directors, Managers and decision makers of leading biopharmaceutical and biotech companies. Register here!
DayOne - Journée d'open innovation organisée par Pierre Fabre - 14 juin 2017. DayOne est une journée unique dédiée à l’innovation pharmaceutique organisée par Pierre Fabre et Cancer Bio Santé. Les projets présélectionnés sur dossier dans les thématiques prioritaires de la R&D Pierre Fabre (oncologie, dermatologie, consumer healthcare) seront présentés par les porteurs de projets lors du DayOne à Toulouse.
Immuno-oncology summit - 28 Aug - 2 Sept 2017 - Boston USA
This year’s IO Summit has been designed to give attendees a complete picture of the field and its advances. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. MabDesign's members benefit from a 20% discount on the registration fees. Ask for your reduction code!
8th World ADC San Diego, USA
20-22 september 2017
World ADC San Diego is the definitive industry forum for accelerating the development of more therapeutically effective antibody-drug conjugates. Annually, over 600 drug developers across 190 key organisations connect at the conference to catch up with peers, build new business relationships and further cement partnerships. MabDesign's members benefit from a 10% discount on the registration fees. Ask for your reduction code!
European Antibody Congress Bâle, Suisse
31 oct. - 2 nov 2017
Every European Antibody Congress brings you the very best speakers from big pharma, biotechs, academia and technology innovators to discuss with you the most exciting breakthroughs when it comes to the discovery and development of antibodies. MabDesign's members benefit from a 20% discount on the registration fees. Ask for your reduction code!
Other news
April 6, 2017 - Nanoparticle-delivered combo boosts cancer immunotherapy. Read more.
April 6, 2017 - Monoclonal Antibody 100% Effective Against Marburg Virus. Read more.
April 3, 2017 - Seattle Genetics Presents Data Advancing Antibody-Drug Conjugate and Novel Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting. Read more.
March 30, 2017 - Novartis gains speedy FDA review for new CAR-T med as Kite race begins. Read more.
March 29, 2017 - How AbbVie Is Attacking Tumors at Their Roots. Read more.
March 28, 2017 - Roche's much-anticipated MS game-changer, Ocrevus, nabs its FDA green light. Read more.
March 28, 2017 - BMS seeks leg up in immuno-oncology with Parker Institute and CRI Pact. Read more.
Check the "Antibodies to watch in 2017" review, by Janice Reichert.
Read more News on Antibodies : PipelineReview
